BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31013298)

  • 1. Structural and diffusion weighted MRI demonstrates responses to ibrutinib in a mouse model of follicular helper (Tfh) T-cell lymphoma.
    Allchin RL; Kelly ME; Mamand S; Doran AG; Keane T; Ahearne MJ; Wagner SD
    PLoS One; 2019; 14(4):e0215765. PubMed ID: 31013298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop.
    Ondrejka SL; Amador C; Climent F; Ng SB; Soma L; Zamo A; Dirnhofer S; Quintanilla-Martinez L; Wotherspoon A; Leoncini L; de Leval L
    Virchows Arch; 2023 Sep; 483(3):349-365. PubMed ID: 37500795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular peripheral T-cell lymphoma expands the spectrum of classical Hodgkin lymphoma mimics.
    Moroch J; Copie-Bergman C; de Leval L; Plonquet A; Martin-Garcia N; Delfau-Larue MH; Molinier-Frenkel V; Belhadj K; Haioun C; Audouin J; Swerdlow SH; Marafioti T; Gaulard P
    Am J Surg Pathol; 2012 Nov; 36(11):1636-46. PubMed ID: 23073322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
    Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
    Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a 5 Marker Panel to the Routine Diagnosis of Peripheral T-Cell Lymphoma With T-Follicular Helper Phenotype.
    Basha BM; Bryant SC; Rech KL; Feldman AL; Vrana JA; Shi M; Reed KA; King RL
    Am J Surg Pathol; 2019 Sep; 43(9):1282-1290. PubMed ID: 31283630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of interleukin-2-inducible kinase (ITK) inhibitors and potential for combination therapies for T-cell lymphoma.
    Mamand S; Allchin RL; Ahearne MJ; Wagner SD
    Sci Rep; 2018 Sep; 8(1):14216. PubMed ID: 30242208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
    Ghione P; Faruque P; Mehta-Shah N; Seshan V; Ozkaya N; Bhaskar S; Yeung J; Spinner MA; Lunning M; Inghirami G; Moskowitz A; Galasso N; Ganesan N; van der Weyden C; Ruan J; Prince HM; Trotman J; Advani R; Dogan A; Horwitz S
    Blood Adv; 2020 Oct; 4(19):4640-4647. PubMed ID: 33002132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
    Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
    Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral T-cell lymphoma with follicular helper of T cell phenotype of Waldeyer's ring: a clinicopathological and genetic study of eight cases].
    Zhang DD; Li P; Hu PZ; Wang GN; Zhao WG; Zhang YP; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):686-692. PubMed ID: 32610379
    [No Abstract]   [Full Text] [Related]  

  • 11. Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.
    Kumar A; Vardhana S; Moskowitz AJ; Porcu P; Dogan A; Dubovsky JA; Matasar MJ; Zhang Z; Younes A; Horwitz SM
    Blood Adv; 2018 Apr; 2(8):871-876. PubMed ID: 29669753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Di-(2-ethylhexyl)-phthalate interferes with T-follicular helper cell differentiation and cytokine secretion through signaling lymphocytic activation molecule family member-1.
    Han Y; Wang X; Pang X; Hu M; Lu Y; Qu J; Chen G
    J Immunotoxicol; 2019 Dec; 16(1):155-163. PubMed ID: 31403359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus.
    Simpson N; Gatenby PA; Wilson A; Malik S; Fulcher DA; Tangye SG; Manku H; Vyse TJ; Roncador G; Huttley GA; Goodnow CC; Vinuesa CG; Cook MC
    Arthritis Rheum; 2010 Jan; 62(1):234-44. PubMed ID: 20039395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on peripheral T-cell lymphomas with T-helper phenotype:  Are there too many subtypes?
    Piris MA; Rodriguez-Pinilla SM; Santonja C; Betancor I; Alonso-Alonso R; Gru AA; Rodriguez M
    Semin Diagn Pathol; 2020 Jan; 37(1):24-31. PubMed ID: 31870687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.
    Ahearne MJ; Allchin RL; Fox CP; Wagner SD
    Br J Haematol; 2014 Aug; 166(3):326-35. PubMed ID: 24815671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent Progress in the Understanding of Angioimmunoblastic T-cell Lymphoma.
    Fujisawa M; Chiba S; Sakata-Yanagimoto M
    J Clin Exp Hematop; 2017; 57(3):109-119. PubMed ID: 29279549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RHOA mutation in follicular T-cell lymphoma: Clinicopathological analysis of 16 cases.
    Miyoshi H; Sakata-Yanagimoto M; Shimono J; Yoshida N; Hattori K; Arakawa F; Yanagida E; Takeuchi M; Yamada K; Suzuki T; Moritsubo M; Furuta T; Chiba S; Ohshima K
    Pathol Int; 2020 Sep; 70(9):653-660. PubMed ID: 32648273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characterization of follicular helper T-cell-derived peripheral T-cell lymphoma involving Waldeyer's ring.
    Wang J; Tang W; Zhang W; Wang J; Chen F; Zhong L; Chen Y; Chen G
    Virchows Arch; 2021 Aug; 479(2):355-363. PubMed ID: 33650043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Cell Lymphoma Patient-Derived Xenograft Models Enable Drug Discovery and Are a Platform for Personalized Therapy.
    Zhang L; Nomie K; Zhang H; Bell T; Pham L; Kadri S; Segal J; Li S; Zhou S; Santos D; Richard S; Sharma S; Chen W; Oriabure O; Liu Y; Huang S; Guo H; Chen Z; Tao W; Li C; Wang J; Fang B; Wang J; Li L; Badillo M; Ahmed M; Thirumurthi S; Huang SY; Shao Y; Lam L; Yi Q; Wang YL; Wang M
    Clin Cancer Res; 2017 Aug; 23(15):4212-4223. PubMed ID: 28348046
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.